Jazz Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.About JAZZ
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio.
JAZZ Key Statistics
Stock Snapshot
The current Jazz Pharmaceuticals(JAZZ) stock price is $169.41, with a market capitalization of 10.29B. The stock trades at a price-to-earnings (P/E) ratio of -27.91.
As of 2026-01-17, Jazz Pharmaceuticals(JAZZ) stock has fluctuated between $167.52 and $172.59. The current price stands at $169.41, placing the stock +1.1% above today's low and -1.8% off the high.
The Jazz Pharmaceuticals(JAZZ)'s current trading volume is 1.08M, compared to an average daily volume of 1.55M.
In the last year, Jazz Pharmaceuticals(JAZZ) shares hit a 52-week high of $182.99 and a 52-week low of $95.49.
In the last year, Jazz Pharmaceuticals(JAZZ) shares hit a 52-week high of $182.99 and a 52-week low of $95.49.
JAZZ News
In recent days, Boehringer Ingelheim announced a clinical collaboration with Jazz Pharmaceuticals to test a combination of zongertinib and Jazz’s bispecific HER...
